Showing 145 results
- https://www.novartis.com/news/industry-and-academia-collaborating-innovate-patients
- https://www.novartis.com/news/fda-grants-priority-review-investigational-targeted-radioligand-therapy-177lu-psma-617-patients-metastatic-castration-resistant-prostate-cancer-mcrpc
- https://www.novartis.com/news/novartis-announces-discontinuation-cirrus-1-study-cfz533-iscalimab-kidney-transplant-patients
- https://www.novartis.com/news/novartis-receives-fda-fast-track-designation-lna043-osteoarthritis-knee
- https://www.novartis.com/news/novartis-sabatolimab-receives-orphan-drug-designation-from-european-commission-myelodysplastic-syndromes
- https://www.novartis.com/news/fda-accelerates-review-novartis-stamp-inhibitor-asciminib-abl001-patients-chronic-myeloid-leukemia-cml
- https://www.novartis.com/news/novartis-receives-fda-orphan-drug-designation-nis793-pancreatic-cancer
- https://www.novartis.com/news/novartis-announces-complete-response-resubmission-inclisiran-new-drug-application
- https://www.novartis.com/news/novartis-receives-fda-breakthrough-therapy-designation-investigational-177lu-psma-617-patients-metastatic-castration-resistant-prostate-cancer-mcrpc
- https://www.novartis.com/news/novartis-entresto-indicated-treatment-hypertension-china